4.6 Article

Resting-State Functional Connectivity Predicts Cognitive Impairment Related to Alzheimer's Disease

期刊

FRONTIERS IN AGING NEUROSCIENCE
卷 10, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2018.00094

关键词

aging; Alzheimer's disease; mild cognitive impairment; functional connectivity; resting state

资金

  1. NIH [MH108591]
  2. US National Science Foundation Graduate Research Fellowship
  3. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  4. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  5. National Institute on Aging
  6. National Institute of Biomedical Imaging and Bioengineering
  7. AbbVie
  8. Alzheimer's Association
  9. Alzheimer's Drug Discovery Foundation
  10. Araclon Biotech
  11. BioClinica, Inc.
  12. Biogen
  13. Bristol-Myers Squibb Company
  14. CereSpir, Inc.
  15. Cogstate
  16. Eisai Inc.
  17. Elan Pharmaceuticals, Inc.
  18. Eli Lilly and Company
  19. EuroImmun
  20. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  21. Fujirebio
  22. GE Healthcare
  23. IXICO Ltd.
  24. Janssen Alzheimer Immunotherapy Research and Development, LLC.
  25. Johnson and Johnson Pharmaceutical Research and Development LLC.
  26. Lumosity
  27. Lundbeck
  28. Merck and Co., Inc.
  29. Meso Scale Diagnostics, LLC.
  30. NeuroRx Research
  31. Neurotrack Technologies
  32. Novartis Pharmaceuticals Corporation
  33. Pfizer Inc.
  34. Piramal Imaging
  35. Servier
  36. Takeda Pharmaceutical Company
  37. Transition Therapeutics
  38. Canadian Institutes of Health Research
  39. Northern California Institute for Research and Education

向作者/读者索取更多资源

Resting-state functional connectivity (rs-FC) is a promising neuromarker for cognitive decline in aging population, based on its ability to reveal functional differences associated with cognitive impairment across individuals, and because rs-fMRI may be less taxing for participants than task-based fMRI or neuropsychological tests. Here, we employ an approach that uses rs-FC to predict the Alzheimer's Disease Assessment Scale (11 items; ADAS11) scores, which measure overall cognitive functioning, in novel individuals. We applied this technique, connectome-based predictive modeling, to a heterogeneous sample of 59 subjects from the Alzheimer's Disease Neuroimaging Initiative, including normal aging, mild cognitive impairment, and AD subjects. First, we built linear regression models to predict ADAS11 scores from rs-FC measured with Pearson's r correlation. The positive network model tested with leave-one-out cross validation (LOOCV) significantly predicted individual differences in cognitive function from rs-FC. In a second analysis, we considered other functional connectivity features, accordance and discordance, which disentangle the correlation and anticorrelation components of activity timecourses between brain areas. Using partial least square regression and LOOCV, we again built models to successfully predict ADAS11 scores in novel individuals. Our study provides promising evidence that rs-FC can reveal cognitive impairment in an aging population, although more development is needed for clinical application. Introduction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据